Desloratadine ratiopharm

RSS

desloratadine

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Desloratadine ratiopharm. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Desloratadine ratiopharm.

This EPAR was last updated on 28/04/2020

Authorisation details

Product details
Name
Desloratadine ratiopharm
Agency product number
EMEA/H/C/002404
Active substance
desloratadine
International non-proprietary name (INN) or common name
desloratadine
Therapeutic area (MeSH)
  • Rhinitis, Allergic, Perennial
  • Urticaria
  • Rhinitis, Allergic, Seasonal
Anatomical therapeutic chemical (ATC) code
R06AX27
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Ratiopharm GmbH
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
13/01/2012
Contact address
Graf-Arco-Str. 3
D-89079 Ulm
Germany

Product information

14/04/2020 Desloratadine ratiopharm - EMEA/H/C/002404 - IB/0024

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antihistamines for systemic use

Therapeutic indication

Relief of symptoms associated with:

  • allergic rhinitis;
  • urticaria.

Assessment history

How useful was this page?

Add your rating